|
Index of reports
> Cases resulting in other serious reactions (33)
> Cases with Suicidal Ideation (6)
Below is the selection of adverse event reports related to Rozerem (Ramelteon) that includes cases resulting in other serious reactions where reactions include suicidal ideation.
Adverse event in female receiving Rozerem (Ramelteon)
Reported by a consumer/non-health professional from United States on 2007-06-15
Patient: female
Adverse reactions / side effects: Blood Pressure Decreased, Somnolence, Suicidal Ideation
Suspect drug(s):
Rozerem (Ramelteon)
Adverse event in female receiving Rozerem (Ramelteon)
Reported by a physician from United States on 2007-06-12
Patient: female
Adverse reactions / side effects: Irritability, Road Traffic Accident, Carbon Monoxide Poisoning, Disturbance in Attention, Drug Interaction, Memory Impairment, Morbid Thoughts, Somnolence, Suicidal Ideation
Suspect drug(s):
Rozerem
Dosage: per oral
Administration route: Oral
Seroquel
Adverse event in receiving Rozerem (Ramelteon)
Reported by a physician from United States on 2007-05-11
Patient:
Adverse reactions / side effects: Feeling Abnormal, Suicidal Ideation
Suspect drug(s):
Rozerem (Ramelteon)
Adverse event in 48 year old female receiving Rozerem (Ramelteon)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-02
Patient: 48 year old female, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Economic Problem, Drug Ineffective, Drug Screen Positive, Family Stress, Hallucination, Auditory, General Physical Health Deterioration, Condition Aggravated, Laceration, Intentional Self-Injury, Suicidal Ideation, Anger, Depression
Adverse event resulted in: hospitalization
Suspect drug(s):
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2006-09-29
End date: 2006-11-29
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Insomnia
Start date: 2006-09-29
End date: 2006-11-29
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Seasonal Affective Disorder
Start date: 2006-09-29
End date: 2006-11-29
Other drugs received by patient: Lamictal; Wellbutrin; Effexor XR; Klonopin
Adverse event in female receiving Rozerem (Ramelteon)
Reported by a individual with unspecified qualification from United States on 2007-04-30
Patient: female
Adverse reactions / side effects: Myalgia, Arthralgia, Insomnia, Depression, Headache, Suicidal Ideation
Suspect drug(s):
Rozerem (Ramelteon)
Other drugs received by patient: Unknown Bipolar Medication (All Other Therapeutic Products); Unknown Depression Medications (All Other Therapeutic Products)
Adverse event in 48 year old female receiving Rozerem (Ramelteon)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-26
Patient: 48 year old female, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Economic Problem, Drug Screen Positive, Hallucination, Auditory, Self Injurious Behaviour, Suicidal Ideation, Cardiac Disorder, Skin Laceration, Anger, Depression
Adverse event resulted in: hospitalization
Suspect drug(s):
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2006-09-29
End date: 2006-11-29
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Insomnia
Start date: 2006-09-29
End date: 2006-11-29
Rozerem
Dosage: 8 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Seasonal Affective Disorder
Start date: 2006-09-29
End date: 2006-11-29
Other drugs received by patient: Lamictal; Wellbutrin; Effexor XR; Klonopin
|